Anti-Integrin beta 4 抗体 [EPR17517]
Anti-Integrin beta 4 antibody [EPR17517]
- RabMAb
- Recombinant
- KO Validated
- 了解详情
5
(3 Reviews)
|
(31 Publications)
Rabbit Recombinant Monoclonal Integrin beta 4 antibody. Suitable for WB, IHC-P and reacts with Mouse, Human samples. Cited in 31 publications.
查看别名
CD104, Integrin beta-4, GP150, ITGB4
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling Integrin beta 4 with ab182120 at 1/250 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Membrane and cytoplasm staining on Human colon epithelium is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Immunohistochemical analysis of paraffin-embedded Human cervical carcinoma tissue labeling Integrin beta 4 with ab182120 at 1/250 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Membrane and cytoplasm staining on Human cervical carcinoma is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Immunohistochemical analysis of paraffin-embedded mouse pancreas tissue labeling Integrin beta 4 with ab182120 at 1/250 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Cell junction staining on mouse pancreatic acinus is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (ab182120) at 1/5000 dilution
All lanes:
SW480 (Human colon adenocarcinoma cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 202 kDa
Observed band size: 210 kDa
false
Exposure time: 5s
- WB
Lab
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Lane 1 : Wild-type HAP1 whole cell lysate (40 μg)
Lane 2 : ITGB4 knockout HAP1 whole cell lysate (40 μg)
Lanes 1 - 2 : Merged signal (red and green). Green - ab182120 observed at 240 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab182120 was shown to specifically recognize ITGB4 in wild-type HAP1 cells alond with additional cross-reactive bands. No band was observed when ITGB4 knockout samples were used. Wild-type and ITGB4 knockout samples were subjected to SDS-PAGE. ab182120 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/30,000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (ab182120)
Predicted band size: 202 kDa
false
- WB
Lab
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Western blot : Anti-ITGB4 antibody [EPR17517] (ab182120) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab182120 was shown to bind specifically to ITGB4. A band was observed at 200 kDa in wild-type A549 cell lysates with no signal observed at this size in ITGB4 knockout cell line. To generate this image, wild-type and ITGB4 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (ab182120) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 40 µg
Lane 2:
ITGB4 knockout A549 cell lysate at 40 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 200 kDa
false
- WB
Supplier Data
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (ab182120) at 1/20000 dilution
All lanes:
Human skin lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 202 kDa
Observed band size: 210 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (ab182120) at 1/1000 dilution
All lanes:
Human pancreas lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 202 kDa
Observed band size: 210 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (ab182120) at 1/1000 dilution
All lanes:
BxPC-3 (Human pancreas adenocarcinoma cells) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 202 kDa
Observed band size: 210 kDa
false
Exposure time: 1s
- WB
Supplier Data
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (ab182120) at 1/1000 dilution
Lane 1:
Mouse pancreas lysate at 10 µg
Lane 2:
Mouse ovary lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 202 kDa
Observed band size: 210 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (ab182120) at 1/1000 dilution
Lane 1:
Mouse spleen lysate at 10 µg
Lane 2:
Mouse kidney lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 202 kDa
Observed band size: 210 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (AB182120)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Integrin beta 4 antibody [EPR17517] (ab182120) at 1/20000 dilution
All lanes:
Mouse skin lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 202 kDa
Observed band size: 210 kDa
false
Exposure time: 15s
不同偶联物与剂型 (3)
-
Anti-Integrin beta 4 antibody [EPR17517] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Integrin beta 4 antibody [EPR17517]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Integrin beta 4 antibody [EPR17517]
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Integrin beta 4 is important for anchoring epithelial cells to the basement membrane stabilizing cell layers in tissues. It interacts with intermediate filaments through specific cytoplasmic proteins. The integrin beta 4 complex ensures structural integrity essential for maintaining the skin and mucosal barriers. Integrations with proteins like M126 are essential for strengthening these interactions safeguarding cellular stability and promoting wound healing.
Pathways
Integrin beta 4 is embedded in key signaling pathways that influence cell adhesion and migration. It participates prominently in the PI3K/AKT and RAS pathway collaborations facilitating signal transduction essential for cell growth and survival. Through these pathways integrin beta 4 interacts with proteins like IS200BPIRG1A linking extracellular cues to internal cellular responses.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (31)
Recent publications for all applications. Explore the full list and refine your search
Cancer cell international 25:253 PubMed40615856
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:5461 PubMed40595493
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta histochemica et cytochemica 58:9-18 PubMed40060360
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell & bioscience 15:15 PubMed39915800
2025
Applications
Unspecified application
Species
Unspecified reactive species
Aging 16:7902-7914 PubMed38709270
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of materials science. Materials in medicine 35:25 PubMed38635066
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:8324 PubMed38594513
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 25:277 PubMed37206547
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer gene therapy 30:414-423 PubMed36385523
2022
Applications
Unspecified application
Species
Unspecified reactive species
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 33:e13871 PubMed36282138
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com